AustralieFrV1, Main, Exploration, bibRecord, 001928

Post-transplant lymphoproliferative disorders.

Identifieur interne : 001928 ( Main/Exploration ); précédent : 001927; suivant : 001929

Post-transplant lymphoproliferative disorders.

Auteurs : Vikas R. Dharnidharka [États-Unis] ; Angela C. Webster [Australie] ; Olivia M. Martinez [États-Unis] ; Jutta K. Preiksaitis [Canada] ; Veronique Leblond [France] ; Sylvain Choquet [France]

Source :

Nature reviews. Disease primers [ 2056-676X ] ; 2016.

RBID : pubmed:27189056

Abstract

Post-transplant lymphoproliferative disorders (PTLDs) are a group of conditions that involve uncontrolled proliferation of lymphoid cells as a consequence of extrinsic immunosuppression after organ or haematopoietic stem cell transplant. PTLDs show some similarities to classic lymphomas in the non-immunosuppressed general population. The oncogenic Epstein-Barr virus (EBV) is a key pathogenic driver in many early-onset cases, through multiple mechanisms. The incidence of PTLD varies with the type of transplant; a clear distinction should therefore be made between the conditions after solid organ transplant and after haematopoietic stem cell transplant. Recipient EBV seronegativity and the intensity of immunosuppression are among key risk factors. Symptoms and signs depend on the localization of the lymphoid masses. Diagnosis requires histopathology, although imaging techniques can provide additional supportive evidence. Pre-emptive intervention based on monitoring EBV levels in blood has emerged as the preferred strategy for PTLD prevention. Treatment of established disease includes reduction of immunosuppression and/or administration of rituximab (a B cell-specific antibody against CD20), chemotherapy and EBV-specific cytotoxic T cells. Despite these strategies, the mortality and morbidity remains considerable. Patient outcome is influenced by the severity of presentation, treatment-related complications and risk of allograft loss. New innovative treatment options hold promise for changing the outlook in the future.

DOI: 10.1038/nrdp.2015.88
PubMed: 27189056

Affiliations:

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Post-transplant lymphoproliferative disorders.</title>
<author><name sortKey="Dharnidharka, Vikas R" sort="Dharnidharka, Vikas R" uniqKey="Dharnidharka V" first="Vikas R" last="Dharnidharka">Vikas R. Dharnidharka</name>
<affiliation wicri:level="4"><nlm:affiliation>Division of Pediatric Nephrology, Washington University School of Medicine, Campus BOX 8116, Room NWT 10-119, 660 South Euclid Avenue, Saint Louis, Missouri 63110, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Pediatric Nephrology, Washington University School of Medicine, Campus BOX 8116, Room NWT 10-119, 660 South Euclid Avenue, Saint Louis, Missouri 63110</wicri:regionArea>
<orgName type="university">École de médecine (Université Washington de Saint-Louis)</orgName>
<placeName><settlement type="city">Saint-Louis (Missouri)</settlement>
<region type="state">Missouri (État)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Webster, Angela C" sort="Webster, Angela C" uniqKey="Webster A" first="Angela C" last="Webster">Angela C. Webster</name>
<affiliation wicri:level="4"><nlm:affiliation>School of Public Health, University of Sydney, Sydney, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>School of Public Health, University of Sydney, Sydney</wicri:regionArea>
<placeName><settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
<settlement type="city">Sydney</settlement>
</placeName>
<orgName type="university">Université de Sydney</orgName>
</affiliation>
</author>
<author><name sortKey="Martinez, Olivia M" sort="Martinez, Olivia M" uniqKey="Martinez O" first="Olivia M" last="Martinez">Olivia M. Martinez</name>
<affiliation wicri:level="2"><nlm:affiliation>Program in Immunology, and the Department of Surgery, Division of Abdominal Transplantation, Stanford University School of Medicine, Stanford, California, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Program in Immunology, and the Department of Surgery, Division of Abdominal Transplantation, Stanford University School of Medicine, Stanford, California</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Preiksaitis, Jutta K" sort="Preiksaitis, Jutta K" uniqKey="Preiksaitis J" first="Jutta K" last="Preiksaitis">Jutta K. Preiksaitis</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Infectious Diseases, University of Alberta, Edmonton, Alberta, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Division of Infectious Diseases, University of Alberta, Edmonton, Alberta</wicri:regionArea>
<wicri:noRegion>Alberta</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Leblond, Veronique" sort="Leblond, Veronique" uniqKey="Leblond V" first="Veronique" last="Leblond">Veronique Leblond</name>
<affiliation wicri:level="4"><nlm:affiliation>Département d'Hématologie, Hôpital Pitie-Salpêtriere, Université Pierre et Marie Curie, GRC11.GRECHY, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Département d'Hématologie, Hôpital Pitie-Salpêtriere, Université Pierre et Marie Curie, GRC11.GRECHY, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
<settlement type="city">Paris</settlement>
</placeName>
<orgName type="university">Université Pierre-et-Marie-Curie</orgName>
</affiliation>
</author>
<author><name sortKey="Choquet, Sylvain" sort="Choquet, Sylvain" uniqKey="Choquet S" first="Sylvain" last="Choquet">Sylvain Choquet</name>
<affiliation wicri:level="4"><nlm:affiliation>Département d'Hématologie, Hôpital Pitie-Salpêtriere, Université Pierre et Marie Curie, GRC11.GRECHY, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Département d'Hématologie, Hôpital Pitie-Salpêtriere, Université Pierre et Marie Curie, GRC11.GRECHY, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
<settlement type="city">Paris</settlement>
</placeName>
<orgName type="university">Université Pierre-et-Marie-Curie</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:27189056</idno>
<idno type="pmid">27189056</idno>
<idno type="doi">10.1038/nrdp.2015.88</idno>
<idno type="wicri:Area/PubMed/Corpus">002458</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002458</idno>
<idno type="wicri:Area/PubMed/Curation">002411</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002411</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002411</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002411</idno>
<idno type="wicri:Area/Ncbi/Merge">003558</idno>
<idno type="wicri:Area/Ncbi/Curation">003558</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003558</idno>
<idno type="wicri:Area/Main/Merge">001923</idno>
<idno type="wicri:Area/Main/Curation">001928</idno>
<idno type="wicri:Area/Main/Exploration">001928</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Post-transplant lymphoproliferative disorders.</title>
<author><name sortKey="Dharnidharka, Vikas R" sort="Dharnidharka, Vikas R" uniqKey="Dharnidharka V" first="Vikas R" last="Dharnidharka">Vikas R. Dharnidharka</name>
<affiliation wicri:level="4"><nlm:affiliation>Division of Pediatric Nephrology, Washington University School of Medicine, Campus BOX 8116, Room NWT 10-119, 660 South Euclid Avenue, Saint Louis, Missouri 63110, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Pediatric Nephrology, Washington University School of Medicine, Campus BOX 8116, Room NWT 10-119, 660 South Euclid Avenue, Saint Louis, Missouri 63110</wicri:regionArea>
<orgName type="university">École de médecine (Université Washington de Saint-Louis)</orgName>
<placeName><settlement type="city">Saint-Louis (Missouri)</settlement>
<region type="state">Missouri (État)</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Webster, Angela C" sort="Webster, Angela C" uniqKey="Webster A" first="Angela C" last="Webster">Angela C. Webster</name>
<affiliation wicri:level="4"><nlm:affiliation>School of Public Health, University of Sydney, Sydney, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>School of Public Health, University of Sydney, Sydney</wicri:regionArea>
<placeName><settlement type="city">Sydney</settlement>
<region type="état">Nouvelle-Galles du Sud</region>
<settlement type="city">Sydney</settlement>
</placeName>
<orgName type="university">Université de Sydney</orgName>
</affiliation>
</author>
<author><name sortKey="Martinez, Olivia M" sort="Martinez, Olivia M" uniqKey="Martinez O" first="Olivia M" last="Martinez">Olivia M. Martinez</name>
<affiliation wicri:level="2"><nlm:affiliation>Program in Immunology, and the Department of Surgery, Division of Abdominal Transplantation, Stanford University School of Medicine, Stanford, California, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Program in Immunology, and the Department of Surgery, Division of Abdominal Transplantation, Stanford University School of Medicine, Stanford, California</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Preiksaitis, Jutta K" sort="Preiksaitis, Jutta K" uniqKey="Preiksaitis J" first="Jutta K" last="Preiksaitis">Jutta K. Preiksaitis</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Infectious Diseases, University of Alberta, Edmonton, Alberta, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Division of Infectious Diseases, University of Alberta, Edmonton, Alberta</wicri:regionArea>
<wicri:noRegion>Alberta</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Leblond, Veronique" sort="Leblond, Veronique" uniqKey="Leblond V" first="Veronique" last="Leblond">Veronique Leblond</name>
<affiliation wicri:level="4"><nlm:affiliation>Département d'Hématologie, Hôpital Pitie-Salpêtriere, Université Pierre et Marie Curie, GRC11.GRECHY, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Département d'Hématologie, Hôpital Pitie-Salpêtriere, Université Pierre et Marie Curie, GRC11.GRECHY, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
<settlement type="city">Paris</settlement>
</placeName>
<orgName type="university">Université Pierre-et-Marie-Curie</orgName>
</affiliation>
</author>
<author><name sortKey="Choquet, Sylvain" sort="Choquet, Sylvain" uniqKey="Choquet S" first="Sylvain" last="Choquet">Sylvain Choquet</name>
<affiliation wicri:level="4"><nlm:affiliation>Département d'Hématologie, Hôpital Pitie-Salpêtriere, Université Pierre et Marie Curie, GRC11.GRECHY, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Département d'Hématologie, Hôpital Pitie-Salpêtriere, Université Pierre et Marie Curie, GRC11.GRECHY, Paris</wicri:regionArea>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
<settlement type="city">Paris</settlement>
</placeName>
<orgName type="university">Université Pierre-et-Marie-Curie</orgName>
</affiliation>
</author>
</analytic>
<series><title level="j">Nature reviews. Disease primers</title>
<idno type="eISSN">2056-676X</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Post-transplant lymphoproliferative disorders (PTLDs) are a group of conditions that involve uncontrolled proliferation of lymphoid cells as a consequence of extrinsic immunosuppression after organ or haematopoietic stem cell transplant. PTLDs show some similarities to classic lymphomas in the non-immunosuppressed general population. The oncogenic Epstein-Barr virus (EBV) is a key pathogenic driver in many early-onset cases, through multiple mechanisms. The incidence of PTLD varies with the type of transplant; a clear distinction should therefore be made between the conditions after solid organ transplant and after haematopoietic stem cell transplant. Recipient EBV seronegativity and the intensity of immunosuppression are among key risk factors. Symptoms and signs depend on the localization of the lymphoid masses. Diagnosis requires histopathology, although imaging techniques can provide additional supportive evidence. Pre-emptive intervention based on monitoring EBV levels in blood has emerged as the preferred strategy for PTLD prevention. Treatment of established disease includes reduction of immunosuppression and/or administration of rituximab (a B cell-specific antibody against CD20), chemotherapy and EBV-specific cytotoxic T cells. Despite these strategies, the mortality and morbidity remains considerable. Patient outcome is influenced by the severity of presentation, treatment-related complications and risk of allograft loss. New innovative treatment options hold promise for changing the outlook in the future.</div>
</front>
</TEI>
<affiliations><list><country><li>Australie</li>
<li>Canada</li>
<li>France</li>
<li>États-Unis</li>
</country>
<region><li>Californie</li>
<li>Missouri (État)</li>
<li>Nouvelle-Galles du Sud</li>
<li>Île-de-France</li>
</region>
<settlement><li>Paris</li>
<li>Saint-Louis (Missouri)</li>
<li>Sydney</li>
</settlement>
<orgName><li>Université Pierre-et-Marie-Curie</li>
<li>Université de Sydney</li>
<li>École de médecine (Université Washington de Saint-Louis)</li>
</orgName>
</list>
<tree><country name="États-Unis"><region name="Missouri (État)"><name sortKey="Dharnidharka, Vikas R" sort="Dharnidharka, Vikas R" uniqKey="Dharnidharka V" first="Vikas R" last="Dharnidharka">Vikas R. Dharnidharka</name>
</region>
<name sortKey="Martinez, Olivia M" sort="Martinez, Olivia M" uniqKey="Martinez O" first="Olivia M" last="Martinez">Olivia M. Martinez</name>
</country>
<country name="Australie"><region name="Nouvelle-Galles du Sud"><name sortKey="Webster, Angela C" sort="Webster, Angela C" uniqKey="Webster A" first="Angela C" last="Webster">Angela C. Webster</name>
</region>
</country>
<country name="Canada"><noRegion><name sortKey="Preiksaitis, Jutta K" sort="Preiksaitis, Jutta K" uniqKey="Preiksaitis J" first="Jutta K" last="Preiksaitis">Jutta K. Preiksaitis</name>
</noRegion>
</country>
<country name="France"><region name="Île-de-France"><name sortKey="Leblond, Veronique" sort="Leblond, Veronique" uniqKey="Leblond V" first="Veronique" last="Leblond">Veronique Leblond</name>
</region>
<name sortKey="Choquet, Sylvain" sort="Choquet, Sylvain" uniqKey="Choquet S" first="Sylvain" last="Choquet">Sylvain Choquet</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001928 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001928 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:27189056
   |texte=   Post-transplant lymphoproliferative disorders.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:27189056" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

Serveur d'exploration sur les relations entre la France et l'Australie

Post-transplant lymphoproliferative disorders.

Post-transplant lymphoproliferative disorders.

Source :

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.